Drug Shortage Report for ONIVYDE
| Report ID | 202912 |
| Drug Identification Number | 02467135 |
| Brand name | ONIVYDE |
| Common or Proper name | IRINOTECAN |
| Company Name | IPSEN BIOPHARMACEUTICALS CANADA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | IRINOTECAN |
| Strength(s) | 4.3MG |
| Dosage form(s) | SUSPENSION |
| Route of administration | INTRAVENOUS INTRAVENOUS |
|
Packaging sizes (GTIN)
Click here to see a list of all reports for this drug. |
(See additional packaging sizes) |
| Additional packaging sizes | 43mg/10mL vial |
| ATC code | L01CE |
| ATC description | |
| Reason for shortage | Other (Please describe in comments) |
| Anticipated start date | |
| Actual start date | 2023-08-18 |
| Estimated end date | Unknown |
| Actual end date | 2024-07-03 |
| Shortage status | Resolved |
| Updated date | 2024-07-04 |
| Company comments | Business reasons |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 5050 SATELLITE DRIVE MISSISSAUGA, ONTARIO CANADA L4W 0G1 |
| Company contact information | [email protected] 1(855) 215-2288 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v4 | 2024-07-04 | French | Compare |
| v3 | 2024-07-04 | English | Compare |
| v2 | 2023-08-24 | French | Compare |
| v1 | 2023-08-24 | English | Compare |
Showing 1 to 4 of 4